GlucoTrack, Inc. (GCTK)
GlucoTrack, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Rutherford, NJ, US. The stock last traded at $0.45, up 2.27% on the session, giving a market capitalisation of $179,582. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 0.72 implies it has historically moved less than the broad market.
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
GlucoTrack, Inc. is most often compared with the following Healthcare names: